Collaborative Use Repurposing Engine (CURE): FDA-NCATS/NIH Effort to Capture the Global Clinical Experience of Drug Repurposing to Facilitate Development of New Treatments for Neglected and Emerging Infectious Diseases

BACKGROUND: Repurposing approved products has proven a critical strategy to serve unmet medical needs. Historically, 40% of drugs approved for treatment of tropical diseases were repurposed, including albendazole for echinococcosis and neurocysticercosis, and azithromycin for trachoma. Advantages of...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Heather, Sacks, Leonard, Tiernan, Rosemary, Duggal, Mili, Sheils, Timothy, Southall, Noel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631680/
http://dx.doi.org/10.1093/ofid/ofx162.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631680/
http://dx.doi.org/10.1093/ofid/ofx162.030

Ejemplares similares